Children's Hospital of Eastern Ontario
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- -
- Established
- 1974-01-01
- Employees
- -
- Market Cap
- -
FDA Places Clinical Hold on Phase 2 Study of PGN-EDO51 in Duchenne Muscular Dystrophy
FDA placed a clinical hold on PepGen's phase 2 CONNECT2-EDO51 study for PGN-EDO51 in DMD patients. CONNECT1-EDO51 study continues in Canada, showing promising exon skipping and dystrophin production at 5 mg/kg dose with good tolerability.
© Copyright 2025. All Rights Reserved by MedPath